UBcare. Co. Ltd
UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more
UBcare. Co. Ltd (032620) - Net Assets
Latest net assets as of September 2025: ₩158.18 Billion KRW
Based on the latest financial reports, UBcare. Co. Ltd (032620) has net assets worth ₩158.18 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩230.43 Billion) and total liabilities (₩72.26 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩158.18 Billion |
| % of Total Assets | 68.64% |
| Annual Growth Rate | 5.88% |
| 5-Year Change | -6.86% |
| 10-Year Change | 118.99% |
| Growth Volatility | 32.35 |
UBcare. Co. Ltd - Net Assets Trend (2011–2024)
This chart illustrates how UBcare. Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for UBcare. Co. Ltd (2011–2024)
The table below shows the annual net assets of UBcare. Co. Ltd from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩99.22 Billion | -12.61% |
| 2023-12-31 | ₩113.54 Billion | -2.71% |
| 2022-12-31 | ₩116.70 Billion | -1.01% |
| 2021-12-31 | ₩117.89 Billion | +10.67% |
| 2020-12-31 | ₩106.52 Billion | +3.85% |
| 2019-12-31 | ₩102.57 Billion | +0.89% |
| 2018-12-31 | ₩101.66 Billion | +118.41% |
| 2017-12-31 | ₩46.55 Billion | -0.02% |
| 2016-12-31 | ₩46.56 Billion | +2.76% |
| 2015-12-31 | ₩45.31 Billion | +14.72% |
| 2014-12-31 | ₩39.49 Billion | -9.92% |
| 2013-12-31 | ₩43.84 Billion | -4.82% |
| 2012-12-31 | ₩46.07 Billion | -2.46% |
| 2011-12-31 | ₩47.23 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to UBcare. Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3512395764000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩35.12 Billion | 35.40% |
| Common Stock | ₩26.10 Billion | 26.30% |
| Other Components | ₩37.99 Billion | 38.29% |
| Total Equity | ₩99.22 Billion | 100.00% |
UBcare. Co. Ltd Competitors by Market Cap
The table below lists competitors of UBcare. Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Wieson Technologies Co Ltd
TWO:6272
|
$62.91 Million |
|
Cox Energy América, S.A.B. de C.V.
MC:COXE
|
$62.91 Million |
|
Lincoln Pharmaceuticals Limited
NSE:LINCOLN
|
$62.93 Million |
|
BIOINVENT INTERN. SK 2
F:BIX0
|
$62.93 Million |
|
Cabral Gold Inc
PINK:CBGZF
|
$62.89 Million |
|
Americas Car-Mart Inc
NASDAQ:CRMT
|
$62.88 Million |
|
Sunjuice Holdings Co Ltd
TW:1256
|
$62.86 Million |
|
Ucloudlink Group Inc
NASDAQ:UCL
|
$62.85 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in UBcare. Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 105,088,504,470 to 99,215,352,930, a change of -5,873,151,540 (-5.6%).
- Net loss of 1,586,166,800 reduced equity.
- Dividend payments of 3,044,558,520 reduced retained earnings.
- Other factors decreased equity by 1,242,426,220.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-1.59 Billion | -1.6% |
| Dividends Paid | ₩3.04 Billion | -3.07% |
| Other Changes | ₩-1.24 Billion | -1.25% |
| Total Change | ₩- | -5.59% |
Book Value vs Market Value Analysis
This analysis compares UBcare. Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.03x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.37x to 2.03x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1174.26 | ₩3960.00 | x |
| 2017-12-31 | ₩1193.97 | ₩3960.00 | x |
| 2018-12-31 | ₩1980.14 | ₩3960.00 | x |
| 2019-12-31 | ₩2021.46 | ₩3960.00 | x |
| 2020-12-31 | ₩2099.31 | ₩3960.00 | x |
| 2021-12-31 | ₩2323.27 | ₩3960.00 | x |
| 2022-12-31 | ₩2299.84 | ₩3960.00 | x |
| 2023-12-31 | ₩2071.01 | ₩3960.00 | x |
| 2024-12-31 | ₩1955.27 | ₩3960.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently UBcare. Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.60%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -0.83%
- • Asset Turnover: 1.19x
- • Equity Multiplier: 1.61x
- Recent ROE (-1.60%) is below the historical average (4.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 7.64% | 6.36% | 1.00x | 1.20x | ₩-1.11 Billion |
| 2012 | 0.65% | 0.47% | 1.08x | 1.29x | ₩-4.42 Billion |
| 2014 | -6.57% | -3.96% | 1.24x | 1.34x | ₩-6.54 Billion |
| 2015 | 13.70% | 10.44% | 0.93x | 1.42x | ₩1.68 Billion |
| 2016 | 10.89% | 7.43% | 1.05x | 1.39x | ₩413.24 Million |
| 2017 | 7.65% | 4.34% | 1.19x | 1.48x | ₩-1.10 Billion |
| 2018 | 5.67% | 5.77% | 0.77x | 1.28x | ₩-4.40 Billion |
| 2019 | 6.63% | 6.13% | 0.81x | 1.33x | ₩-3.46 Billion |
| 2020 | 5.85% | 5.78% | 0.70x | 1.45x | ₩-4.42 Billion |
| 2021 | 11.29% | 11.91% | 0.75x | 1.27x | ₩1.52 Billion |
| 2022 | 3.07% | 2.69% | 0.82x | 1.39x | ₩-8.08 Billion |
| 2023 | -1.63% | -1.11% | 0.99x | 1.47x | ₩-12.22 Billion |
| 2024 | -1.60% | -0.83% | 1.19x | 1.61x | ₩-11.51 Billion |
Industry Comparison
This section compares UBcare. Co. Ltd's net assets metrics with peer companies in the Software & IT Services industry.
Industry Context
- Industry: Software & IT Services
- Average net assets among peers: $49,914,939,566
- Average return on equity (ROE) among peers: -9.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| UBcare. Co. Ltd (032620) | ₩158.18 Billion | 7.64% | 0.46x | $62.90 Million |
| Daishin Information & Communications Co.Ltd (020180) | $23.68 Billion | 6.99% | 1.25x | $22.09 Million |
| PLAYWITH Inc (023770) | $25.93 Billion | -23.11% | 0.68x | $6.30 Million |
| Dragonfly GF Co. Ltd (030350) | $28.36 Billion | -97.50% | 0.33x | $9.22 Million |
| Softcen Co. Ltd (032680) | $31.47 Billion | 0.00% | 0.35x | $4.89 Million |
| InfoBank Corporation (039290) | $61.17 Billion | 2.36% | 0.46x | $15.68 Million |
| Korea Business News Co. Ltd (039340) | $138.21 Billion | 13.77% | 0.26x | $22.06 Million |
| Total Soft Bank Ltd (045340) | $21.85 Billion | 17.29% | 0.60x | $26.79 Million |
| DAEA TI Co. Ltd (045390) | $88.26 Billion | 8.00% | 0.44x | $166.31 Million |
| ESTsoft Corp (047560) | $30.29 Billion | -9.09% | 1.71x | $64.92 Million |